In contrast, CSF NfL levels were elevated in patients with ALS and dementia, corroborating the role of this biomarker in these neurodegenerative diseases (Narayanan et al. 2021; Khalil et al. 2024, 2018). This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.